Analyst Expectations for Elanco Animal Health's Future
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 Wall Street analysts have provided their opinions on Elanco Animal Health (NYSE:ELAN), all maintaining an indifferent stance with no bullish or bearish ratings. The average 12-month price target for ELAN is $13.25, with a high of $16.00 and a low of $12.00, unchanged from the previous average. Analysts typically review stocks quarterly or after major company updates, considering financials, growth estimates, earnings, and revenue.
December 07, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Elanco Animal Health has received an indifferent consensus rating from 4 analysts over the past 3 months, with an average price target of $13.25. The target remains unchanged, indicating stability in analysts' expectations.
The indifferent ratings from analysts suggest that there is no strong sentiment that could drive the stock price significantly in either direction in the short term. The unchanged price target over the past 3 months indicates that analysts have not altered their expectations about the company's performance, which could lead to a neutral short-term impact on the stock price.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100